Evidence map›Paper›PMID 41516075›Full record

ArticleInternational journal of molecular sciences2025

Temporal Dynamics of Pulmonary Fibrosis and Immune Dysregulation in a Collagen V-Driven Systemic Sclerosis Model.

Vitória Elias Contini, Zelita Aparecida J Queiroz, Sérgio Catanozi, Antonio Dos Santos Filho, Lizandre Keren Ramos da Silveira, Aritania Sousa Santos, Sandra de Morais Fernezlian, Denise Frediani, Thays de Matos Lobo, Jaíne Alves Almeida and 5 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Vitória Elias ContiniDivisão de Reumatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Zelita Aparecida J QueirozDivisão de Reumatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Sérgio CatanoziLaboratório de Lipides (LIM-10), Hospital das Clinicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Antonio Dos Santos FilhoDivisão de Reumatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Lizandre Keren Ramos da SilveiraDivisão de Reumatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Aritania Sousa SantosLaboratório de Carboidratos e Radioimunoensaio (LIM 18), Hospital das Clinicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.ORCID 0000-0003-4091-5777
Sandra de Morais FernezlianDepartamento de Patologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Denise FredianiDepartamento de Emergência (LIM 51), Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Thays de Matos LoboDivisão de Reumatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Jaíne Alves AlmeidaDivisão de Reumatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Camila Machado BaldaviraDepartamento de Patologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.ORCID 0000-0002-5364-7305
Ana Paula Pereira VelosaDivisão de Reumatologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Percival Degrava Sampaio-BarrosDivisão de Reumatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Vera Luiza CapelozziDepartamento de Patologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.ORCID 0000-0001-9732-5853
Walcy Rosolia TeodoroDivisão de Reumatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) Finance Code 001São Paulo Research Foundation (FAPESP) 2018/00415-0São Paulo Research Foundation (FAPESP) 218/20403-6Sociedade Brasileira de Reumatologia, Brazil 2023-16
6 · The paper itself

Abstract

Systemic sclerosis (SSc) is a complex autoimmune disease characterized by progressive fibrosis and immune dysregulation, with lung involvement being a major cause of morbidity and mortality. Type V collagen (COLV), a cryptic self-antigen, has been implicated in the pathogenesis of fibrosis in both SSc and lung allograft dysfunction. To characterize the early histological, molecular, and immunological events associated with lung remodeling following immunization with COLV in a murine model (IMU-COLV), and to establish a temporal framework for fibrosis progression. Using a time-course design, lung tissue from IMU-COLV mice was analyzed at multiple intervals post-immunization. Histopathological assessment, immunohistochemistry, and gene expression analysis were performed to evaluate inflammation, endothelial activation, extracellular matrix remodeling, and collagen composition. We observed a progressive and spatially organized pattern of lung remodeling, beginning with peribronchovascular immune infiltration and culminating in airway-centered fibrosis. These changes were accompanied by dynamic endothelial activation, increased expression of profibrotic markers, and alterations in collagen architecture particularly involving COLV. The remodeling pattern closely mirrors histological features observed in early SSc-associated interstitial lung disease and other fibrotic conditions, such as idiopathic pulmonary fibrosis and chronic lung allograft dysfunsion. The IMU-COLV model recapitulates key early features of SSc-related lung fibrosis, highlighting COLV's potential role as a driver of immune-mediated tissue remodeling. These findings provide a valuable platform for investigating the mechanisms underlying fibrogenesis and for testing targeted interventions in the early phases of pulmonary fibrosis.

Indexed as

Collagen Type VPulmonary FibrosisScleroderma, SystemicAnimalsDisease Models, AnimalLungMiceCollagen Type Vcollagen VlungSSc experimental modelsystemic sclerosis

Identifiers

PMID41516075
PMCPMC12786071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.